Functional differences between two Tie2 ligands, angiopoietin-1 and -2, in regulation of adult bone marrow hematopoietic stem cells

Experimental Hematology

Volumn 38, Issue 2, 2010, Pages

  Gomei, Yumiko ^a   Nakamura, Yuka ^a   Yoshihara, Hiroki ^a   Hosokawa, Kentaro ^a   Iwasaki, Hiroko ^a   Suda, Toshio ^a   Arai, Fumio ^a  

^a Institute of DNA Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; BETA1 INTEGRIN; BETA2 INTEGRIN; BMI1 PROTEIN; CHEMOKINE RECEPTOR CXCR4; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYCLIN DEPENDENT KINASE INHIBITOR 2C; HOMEODOMAIN PROTEIN; PROTEIN KINASE B; PROTEIN P18; PROTEIN P57; STEM CELL ANTIGEN 1; STEM CELL FACTOR RECEPTOR; THROMBOPOIETIN RECEPTOR; TRANSCRIPTION FACTOR HOXB4; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL ACTIVITY; CELL CULTURE; CELL LINEAGE; CELL POPULATION; COLONY FORMATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 73949131170     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.11.007     Document Type: Article

References (30)

1. Moore K.A., and Lemischka I.R. Stem cells and their niches. Science 311 (2006) 1880-1885
2. Wilson A., and Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 6 (2006) 93-106
3. Yin T., and Li L. The stem cell niches in bone. J Clin Invest 116 (2006) 1195-1201
4. Xie T., and Li L. Stem cells and their niche: an inseparable relationship. Development 134 (2007) 2001-2006
5. Lin H. The stem-cell niche theory: lessons from flies. Nat Rev Genet 3 (2002) 931-940
6. Arai F., Hirao A., Ohmura M., et al. Tie2/Angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118 (2004) 149-161
7. Sacchetti B., Funari A., Michienzi S., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131 (2007) 324-336
8. Davis S., Aldrich T.H., Jones P.F., et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87 (1996) 1161-1169
9. Davis S., Papadopoulos N., Aldrich T.H., et al. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat Struct Biol 10 (2003) 38-44
10. Gale N.W., Thurston G., Hackett S.F., et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev Cell 3 (2002) 411-423
11. Maisonpierre P.C., Suri C., Jones P.F., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
12. Suri C., Jones P.F., Patan S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
13. Valenzuela D.M., Griffiths J.A., Rojas J., et al. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci U S A 96 (1999) 1904-1909
14. Gale N.W., and Yancopoulos G.D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13 (1999) 1055-1066
15. Ward N.L., and Dumont D.J. The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development. Semin Cell Dev Biol 13 (2002) 19-27
16. Puri M.C., and Bernstein A. Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis. Proc Natl Acad Sci U S A 100 (2003) 12753-12758
17. Cho C.H., Kammerer R.A., Lee H.J., et al. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci U S A 101 (2004) 5547-5552
18. Sato T., Onai N., Yoshihara H., Arai F., Suda T., and Ohteki T. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med 15 (2009) 696-700
19. Kim I., Kim H.G., So J.N., Kim J.H., Kwak H.J., and Koh G.Y. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ Res 86 (2000) 24-29
20. Shiojima I., and Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90 (2002) 1243-1250
21. Antonchuk J., Sauvageau G., and Humphries R.K. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109 (2002) 39-45
22. Sauvageau G., Thorsteinsdottir U., Eaves C.J., et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev 9 (1995) 1753-1765
23. Park I.K., Qian D., Kiel M., et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423 (2003) 302-305
24. Iwama A., Oguro H., Negishi M., et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 21 (2004) 843-851
25. Hosokawa K, Arai F, Yoshihara H, et al. Cadherin-based adhesion is a potential target for niche manipulation to protect hematopoietic stem cells in adult bone marrow. Cell Stem Cell. In press.
26. Bowen M.A., Patel D.D., Li X., et al. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 181 (1995) 2213-2220
27. Arai F., Ohneda O., Miyamoto T., Zhang X.Q., and Suda T. Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. J Exp Med 195 (2002) 1549-1563
28. Ohneda O., Ohneda K., Arai F., et al. ALCAM (CD166): its role in hematopoietic and endothelial development. Blood 98 (2001) 2134-2142
29. Haug J.S., He X.C., Grindley J.C., et al. N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells. Cell Stem Cell 2 (2008) 367-379
30. Adams G.B., Martin R.P., Alley I.R., et al. Therapeutic targeting of a stem cell niche. Nat Biotechnol 25 (2007) 238-243